Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia

Bruce D. Cheson, John C. Byrd, Kanti R. Rai, Neil E. Kay, Susan M. O'Brien, Ian W. Flinn, Adrian Wiestner, Thomas J. Kipps

Research output: Contribution to journalComment/debate

141 Scopus citations
Original languageEnglish (US)
Pages (from-to)2820-2822
Number of pages3
JournalJournal of Clinical Oncology
Volume30
Issue number23
DOIs
StatePublished - Aug 22 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cheson, B. D., Byrd, J. C., Rai, K. R., Kay, N. E., O'Brien, S. M., Flinn, I. W., Wiestner, A., & Kipps, T. J. (2012). Novel targeted agents and the need to refine clinical end points in chronic lymphocytic leukemia. Journal of Clinical Oncology, 30(23), 2820-2822. https://doi.org/10.1200/JCO.2012.43.3748